MAI Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3K | Sell |
|
|||||
|
2025
Q1 | $29.1K | Sell |
|
|||||
|
2024
Q4 | $330K | Sell |
|
|||||
|
2024
Q3 | $1.52M | Buy |
|
|||||
|
2024
Q2 | $1.63M | Buy |
|
|||||
|
2024
Q1 | $2.21M | Buy |
|
|||||
|
2023
Q4 | $876K | Sell |
|
|||||
|
2023
Q3 | $1.13M | Buy |
|
|||||
|
2023
Q2 | $1.34M | Buy |
|
|||||
|
2023
Q1 | $638K | Sell |
|
|||||
|
2022
Q4 | $534K | Sell |
|
|||||
|
2022
Q3 | $590K | Buy |
|
|||||
|
2022
Q2 | $391K | Buy |
|